Developer docs
API playgroundTry for free, no card

Search company profiles

NuVasive

Full company profile

uuid0007qnc

Namestring
NuVasive
Legal namestring
NUVASIVE®, INC.
Websiteurl
nuvasive.com
Company typeenum
Private
Founded yearint
2001
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices19 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spinal surgery implants, minimally invasive spine surgery, robotic surgical navigation, intraoperative neuromonitoring services, medical device manufacturing
Industry4 codes
1Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
CodeHLAHAEACPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
33D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
4Spine (Orthopedic Spine)
CodeHLAKALAEPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Spinal Surgery Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Spinal implants and surgical instruments
TypeHardware Sales
Description

Sale of spinal implants including interbody spacers, fixation systems, and surgical instruments for various spinal procedures including XLIF, TLIF, ACDF, and deformity correction.

finance.yahoo.com
2Enabling technologies
TypeHardware Sales
Description

Robotic navigation systems, neuromonitoring services, and imaging technology that complement surgical procedures.

nuvasive.com
3Biologics and regenerative products
TypeHardware Sales
Description

Regenerative biologics including amniotic membrane, autologous PRP/BMAC, cellular allograft, DBM/allograft, and synthetic graft materials.

finance.yahoo.com
4Intraoperative neuromonitoring services (NCS)
TypeProfessional Services
Description

Clinical services providing best-in-class IONM experience serving over 100,000 cases annually with board-certified neurologists and neurophysiologists.

nuvasive.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Medical device products sold through direct hospital contracts
ModelOther
Notes

Pricing negotiated through hospital purchasing contracts and group purchasing organizations (GPOs). No public pricing available.

nuvasive.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1X360
Description

Comprehensive lateral single-position surgery system integrating XLIF, XALIF, and XFixation procedures with Surgical Intelligence technologies

nuvasive.com
+9 more records
Core offering1 text field

NuVasive designs, manufactures, and sells medical devices for spine surgery, including spinal implants (interbody spacers, fixation systems), minimally invasive surgical platforms (X360 lateral single-position surgery, XLIF), advanced biomaterials (Modulus, HEDRON, Cohere porous titanium/PEEK implants), robotic navigation systems (ExcelsiusGPS, ExcelsiusHub), intraoperative neuromonitoring (NVM5, NCS clinical services), and regenerative biologics. Products are sold directly to hospitals, ambulatory surgery centers, and spine surgeons globally across 40+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Reduced OR time by up to 60 minutes per procedure
+5 more records
Product overview1 text field

NuVasive (now part of Globus Medical following 2023 merger) offers a comprehensive portfolio of spine surgery solutions organized around three core technology pillars: (1) X360 System - the comprehensive lateral single-position surgery platform integrating XLIF, XALIF, and XFixation procedures; (2) Advanced Materials Science - porous implant technologies including Modulus (titanium), HEDRON (3D-printed titanium), and Cohere (porous PEEK) designed for enhanced osseointegration; (3) Excelsius Technology ecosystem - robotic navigation and enabling technologies including ExcelsiusGPS, ExcelsiusHub, ExcelsiusXR, ExcelsiusFlex, and Excelsius3D. Supporting these are fixation systems (Reline, TLIF, Armada, VuePoint), interbody solutions (CoRoent, TLX, XCore), motion preservation (Simplify Cervical Disc), pediatric solutions (MAGEC, Reline Small Stature), neuromonitoring (NVM5, NCS Clinical Services), regenerative biologics, and power tools (DuraPro, Verzera). The portfolio is enhanced by integrated Global Alignment (iGA) platform for spinopelvic parameter assessment and the Pulse technology platform combining neuromonitoring, navigation, and imaging enhancement.

Product and service22 records
1X360 System
CategorySurgical Platform
Description

Comprehensive lateral single-position surgery platform integrating XLIF, XALIF, and XFixation procedures, designed to reduce OR time by up to 60 minutes and save nearly $5,000 per patient in hospital costs for spine surgeons and hospitals.

2Pulse Platform
CategoryEnabling Technology Platform
Description

Integrated technology platform combining neuromonitoring, global alignment, navigation, rod bending, radiation reduction, and imaging enhancement in a single expandable system for spine surgeons.

3Advanced Materials Science Implants (Modulus, HEDRON, Cohere)
CategorySpinal Implants
Description

Portfolio of porous titanium (Modulus, HEDRON) and porous PEEK (Cohere) interbody implant technologies designed to enhance osseointegration, biomechanical properties, and fusion outcomes for spine surgery patients.

4ExcelsiusGPS Robotic Navigation System
CategoryRobotic Surgical Navigation
Description

Robotic navigation system for spine surgery providing autonomous targeting and trajectory planning with CT-based preoperative planning and real-time intraoperative navigation for spine surgeons and hospitals.

5ExcelsiusHub Navigation Platform
CategoryRobotic Surgical Navigation
Description

Newest spine navigation platform with real-time patient array monitoring and tissue-sparing drills designed to elevate surgical safety and reproducibility for spine surgeons.

6ExcelsiusFlex Robotic Navigation System
CategoryRobotic Surgical Navigation
Description

Robotic navigation and surgical guidance system designed for reconstructive orthopedic surgery applications beyond spine.

7ExcelsiusXR Augmented Reality Surgical Navigation
CategoryRobotic Surgical Navigation
Description

AR headset providing augmented reality surgical navigation for enhanced visualization during spine procedures.

8Excelsius3D Intraoperative Imaging System
CategoryIntraoperative Imaging
Description

3D imaging system for intraoperative visualization and planning supporting robotic navigation workflows in spine surgery.

9Reline Posterior Fixation System
CategorySpinal Fixation
Description

Evolution of posterior fixation technology providing integrated Open and MAS procedural solutions for preserving or restoring spinal alignment; includes Reline MAS, Reline 3D, and Reline Small Stature variants for spine surgeons.

10TLIF Portfolio (including MAS TLIF 2)
CategorySpinal Interbody / Fixation
Description

Transforaminal Lumbar Interbody Fusion portfolio providing open and MAS systems for TLIF procedures; MAS TLIF 2 is next-generation pedicle-based retractor with maximum visibility for spine surgeons.

11CoRoent Interbody Implants
CategorySpinal Interbody Implants
Description

Family of PEEK interbody implants including multiple configurations (LI, LO, LC, LT, LW, Small Interlock for ACDF) using patented Insert and Rotate technique for various surgical approaches.

12Simplify Cervical Disc
CategoryCervical Disc Replacement
Description

Motion-preserving cervical disc replacement device with PEEK on ceramic composition, anatomical sizing, variable rotation center, and MRI visibility for cervical disc replacement procedures.

13MAGEC Magnetic Growing Rods
CategoryPediatric Spine Implants
Description

Magnetic growing rod system using an external remote controller (ERC) for non-invasive repeated distraction to treat early-onset scoliosis (EOS) without repeated surgeries in pediatric spine patients.

14XCore/XCore 2 Expandable Vertebral Body Replacement
CategorySpinal Reconstruction
Description

Expandable vertebral body replacement (VBR) system for modular corpectomy applications with multiple approach options; XCore 2 features XLIF-style endplates for higher subsidence resistance.

15TLX 20° Expandable Cage
CategorySpinal Interbody Implants
Description

Expandable cage for posterior approach providing anterior column stability and sagittal alignment restoration with up to 20 degrees of customizable oblique lordosis.

16Armada Thoracolumbar Fixation System
CategorySpinal Fixation
Description

Thoracolumbar fixation system with sophisticated instrumentation and implants for treating pathologies ranging from degenerative to complex deformity in spine surgery.

17VuePoint Occipital-Cervical-Thoracic Fixation
CategorySpinal Fixation
Description

Occipital-cervical-thoracic fixation systems (VuePoint 1 and 2) for treating simple to complex deformity pathologies with low-profile multi-axial screws.

18Integrated Global Alignment (iGA) Platform
CategorySurgical Planning Software
Description

Software platform providing spinopelvic parameter calculation, intraoperative real-time alignment assessment, and correlation with clinical outcomes for spine deformity correction.

19NVM5 Intraoperative Neuromonitoring System
CategoryIntraoperative Neuromonitoring
Description

Intraoperative neuromonitoring system providing real-time monitoring of SSEP, EMG, MEP, BAER, DBS, and cortical mapping during spine and other surgeries for hospitals and surgeons.

20NCS Neuromonitoring Clinical Services
CategoryClinical Monitoring Services
Description

Clinical services providing best-in-class intraoperative neurophysiological monitoring (IONM) with board-certified neurologists and neurophysiologists serving over 100,000 cases annually; certified by The Joint Commission.

21Power Portfolio (DuraPro, Verzera)
CategorySurgical Power Tools
Description

Surgical power tools including the DuraPro oscillating system and Verzera navigated high speed drill designed to integrate with enabling technology for streamlined surgical workflows.

22Regenerative Biologics Portfolio
CategorySpinal Biologics
Description

Regenerative biologics portfolio including amniotic membrane, autologous PRP/BMAC/adipose, cellular allograft, DBM/allograft, graft delivery, and synthetic bone graft substitutes for spine surgery.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-02-01
Description

Globus Medical completed acquisition of NuVasive for $3.1 billion in February 2023, creating one of the largest entities in the spine and musculoskeletal space. The merger combined Globus Medical's Excelsius robotic platform with NuVasive's X360 lateral surgery portfolio and Advanced Materials Science technologies.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medtronic is NuVasive's largest direct competitor across spine implants, robotic navigation (Mazor), and intraoperative neuromonitoring (NVM5 competes with Medtronic's nerve monitoring portfolio that holds 18% global share versus NuVasive's 15%).

TypeBroad incumbent
Description

Stryker is a diversified medtech incumbent with a meaningful spine and neurosurgery franchise (including acquired Wright Medical assets) plus the Mako orthopedic robotics platform, positioning it as a broad competitor in robotic-enabled surgery that overlaps with ExcelsiusGPS.

TypeBroad incumbent
Description

Johnson & Johnson's DePuy Synthes spine division competes with NuVasive across interbody devices, fixation, and emerging enabling technologies; the broader J&J medtech R&D and capital resources make it a deep-pocketed incumbent competitor.

TypeBroad incumbent
Description

Zimmer Biomet competes in spine via its spine and CMFT portfolio and offers the ROSA robotic platform for spine and brain surgery, overlapping with ExcelsiusGPS navigation and NuVasive's broader Enabling Tech push into orthopedics through ExcelsiusFlex.

TypeDirect peer
Description

Alphatec is a pure-play spine company offering lateral, posterior fixation, and biologics portfolios that directly overlap with NuVasive's X360, Reline, and regenerative biologics lines, with significant share of voice in the surgeon training and lateral approach segments.

TypeDirect peer
Description

Orthofix (which merged with SeaSpine) competes with NuVasive across spine implants, fixation, motion preservation, and orthobiologics, and overlaps in the pediatric/EOS segment where NuVasive's MAGEC rod competes with Orthofix's pediatric portfolio.

TypeBroad incumbent
Description

Boston Scientific overlaps with NuVasive through its neuromodulation and pain franchise (including spinal cord stimulation platforms) that competes with NuVasive's neuromonitoring and adjacent chronic pain opportunities, particularly after Nevro joined Globus Medical.

TypeEmerging player
Description

Brainlab is a navigation and surgical software specialist whose spine imaging and computer-assisted surgery platform competes with NuVasive's ExcelsiusHub and Excelsius3D in the navigation-only segment of the enabling-tech stack.

TypeOthers
Description

Nevro (acquired by Globus Medical in 2025) provides the HFX spinal cord stimulation platform for chronic pain; not a NuVasive competitor per se but a now-sibling asset within the combined Globus-NuVasive platform expanding into neuromodulation.

TypeOthers
Description

ZEISS Medical Technology supplies intraoperative imaging and visualization hardware that integrates with multiple surgical robotics platforms (including competitive offerings with Globus/NuVasive Excelsius workflows) and serves as a complementary or substitute imaging source in spine ORs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries14 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NuVasive

Spinal Surgery Medical Devicesnuvasive.com

NuVasive firmographics

Firmographics
Name
NuVasive
Legal name
NUVASIVE®, INC.
Website
https://nuvasive.com
Company type
Private
Founded year
2001
Operating status
Acquired
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

NuVasive industry classification

Industry
Product category
Spinal Surgery Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)
akta.pro secondary industries
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Spine (Orthopedic Spine) (HLAKALAE)

Keywords

  • Spinal surgery implants
  • Minimally invasive spine surgery
  • Robotic surgical navigation
  • Intraoperative neuromonitoring services
  • Medical device manufacturing

Where NuVasive is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices19 records

Markets served

NuVasive business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Spinal implants and surgical instruments: Sale of spinal implants including interbody spacers, fixation systems, and surgical instruments for various spinal procedures including XLIF, TLIF, ACDF, and deformity correction.
  2. Enabling technologies: Robotic navigation systems, neuromonitoring services, and imaging technology that complement surgical procedures.
  3. Biologics and regenerative products: Regenerative biologics including amniotic membrane, autologous PRP/BMAC, cellular allograft, DBM/allograft, and synthetic graft materials.
  4. Intraoperative neuromonitoring services (NCS): Clinical services providing best-in-class IONM experience serving over 100,000 cases annually with board-certified neurologists and neurophysiologists.

Pricing tiers

ModelBillingPrice
Other—Medical device products sold through direct hospital contracts

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

NuVasive product offering

Product offering

Core offering

NuVasive designs, manufactures, and sells medical devices for spine surgery, including spinal implants (interbody spacers, fixation systems), minimally invasive surgical platforms (X360 lateral single-position surgery, XLIF), advanced biomaterials (Modulus, HEDRON, Cohere porous titanium/PEEK implants), robotic navigation systems (ExcelsiusGPS, ExcelsiusHub), intraoperative neuromonitoring (NVM5, NCS clinical services), and regenerative biologics. Products are sold directly to hospitals, ambulatory surgery centers, and spine surgeons globally across 40+ countries.

Product overview

NuVasive (now part of Globus Medical following 2023 merger) offers a comprehensive portfolio of spine surgery solutions organized around three core technology pillars: (1) X360 System - the comprehensive lateral single-position surgery platform integrating XLIF, XALIF, and XFixation procedures; (2) Advanced Materials Science - porous implant technologies including Modulus (titanium), HEDRON (3D-printed titanium), and Cohere (porous PEEK) designed for enhanced osseointegration; (3) Excelsius Technology ecosystem - robotic navigation and enabling technologies including ExcelsiusGPS, ExcelsiusHub, ExcelsiusXR, ExcelsiusFlex, and Excelsius3D. Supporting these are fixation systems (Reline, TLIF, Armada, VuePoint), interbody solutions (CoRoent, TLX, XCore), motion preservation (Simplify Cervical Disc), pediatric solutions (MAGEC, Reline Small Stature), neuromonitoring (NVM5, NCS Clinical Services), regenerative biologics, and power tools (DuraPro, Verzera). The portfolio is enhanced by integrated Global Alignment (iGA) platform for spinopelvic parameter assessment and the Pulse technology platform combining neuromonitoring, navigation, and imaging enhancement.

Differentiator

Problem solved

Functional benefit

Brands

  • X360: Comprehensive lateral single-position surgery system integrating XLIF, XALIF, and XFixation procedures with Surgical Intelligence technologies
  • Modulus
  • Reline
  • Pulse
  • MAGEC
  • Simplify
  • NVM5
  • Cohere
  • HEDRON
  • TLX

Products and services

  • X360 System Comprehensive lateral single-position surgery platform integrating XLIF, XALIF, and XFixation procedures, designed to reduce OR time by up to 60 minutes and save nearly $5,000 per patient in hospital costs for spine surgeons and hospitals.
  • Pulse Platform Integrated technology platform combining neuromonitoring, global alignment, navigation, rod bending, radiation reduction, and imaging enhancement in a single expandable system for spine surgeons.
  • Advanced Materials Science Implants (Modulus, HEDRON, Cohere) Portfolio of porous titanium (Modulus, HEDRON) and porous PEEK (Cohere) interbody implant technologies designed to enhance osseointegration, biomechanical properties, and fusion outcomes for spine surgery patients.
  • ExcelsiusGPS Robotic Navigation System Robotic navigation system for spine surgery providing autonomous targeting and trajectory planning with CT-based preoperative planning and real-time intraoperative navigation for spine surgeons and hospitals.
  • ExcelsiusHub Navigation Platform Newest spine navigation platform with real-time patient array monitoring and tissue-sparing drills designed to elevate surgical safety and reproducibility for spine surgeons.
  • ExcelsiusFlex Robotic Navigation System Robotic navigation and surgical guidance system designed for reconstructive orthopedic surgery applications beyond spine.
  • ExcelsiusXR Augmented Reality Surgical Navigation AR headset providing augmented reality surgical navigation for enhanced visualization during spine procedures.
  • Excelsius3D Intraoperative Imaging System 3D imaging system for intraoperative visualization and planning supporting robotic navigation workflows in spine surgery.
  • Reline Posterior Fixation System Evolution of posterior fixation technology providing integrated Open and MAS procedural solutions for preserving or restoring spinal alignment; includes Reline MAS, Reline 3D, and Reline Small Stature variants for spine surgeons.
  • TLIF Portfolio (including MAS TLIF 2) Transforaminal Lumbar Interbody Fusion portfolio providing open and MAS systems for TLIF procedures; MAS TLIF 2 is next-generation pedicle-based retractor with maximum visibility for spine surgeons.
  • CoRoent Interbody Implants Family of PEEK interbody implants including multiple configurations (LI, LO, LC, LT, LW, Small Interlock for ACDF) using patented Insert and Rotate technique for various surgical approaches.
  • Simplify Cervical Disc Motion-preserving cervical disc replacement device with PEEK on ceramic composition, anatomical sizing, variable rotation center, and MRI visibility for cervical disc replacement procedures.
  • MAGEC Magnetic Growing Rods Magnetic growing rod system using an external remote controller (ERC) for non-invasive repeated distraction to treat early-onset scoliosis (EOS) without repeated surgeries in pediatric spine patients.
  • XCore/XCore 2 Expandable Vertebral Body Replacement Expandable vertebral body replacement (VBR) system for modular corpectomy applications with multiple approach options; XCore 2 features XLIF-style endplates for higher subsidence resistance.
  • TLX 20° Expandable Cage Expandable cage for posterior approach providing anterior column stability and sagittal alignment restoration with up to 20 degrees of customizable oblique lordosis.
  • Armada Thoracolumbar Fixation System Thoracolumbar fixation system with sophisticated instrumentation and implants for treating pathologies ranging from degenerative to complex deformity in spine surgery.
  • VuePoint Occipital-Cervical-Thoracic Fixation Occipital-cervical-thoracic fixation systems (VuePoint 1 and 2) for treating simple to complex deformity pathologies with low-profile multi-axial screws.
  • Integrated Global Alignment (iGA) Platform Software platform providing spinopelvic parameter calculation, intraoperative real-time alignment assessment, and correlation with clinical outcomes for spine deformity correction.
  • NVM5 Intraoperative Neuromonitoring System Intraoperative neuromonitoring system providing real-time monitoring of SSEP, EMG, MEP, BAER, DBS, and cortical mapping during spine and other surgeries for hospitals and surgeons.
  • NCS Neuromonitoring Clinical Services Clinical services providing best-in-class intraoperative neurophysiological monitoring (IONM) with board-certified neurologists and neurophysiologists serving over 100,000 cases annually; certified by The Joint Commission.
  • Power Portfolio (DuraPro, Verzera) Surgical power tools including the DuraPro oscillating system and Verzera navigated high speed drill designed to integrate with enabling technology for streamlined surgical workflows.
  • Regenerative Biologics Portfolio Regenerative biologics portfolio including amniotic membrane, autologous PRP/BMAC/adipose, cellular allograft, DBM/allograft, graft delivery, and synthetic bone graft substitutes for spine surgery.

Quantifiable outcome

  • Reduced OR time by up to 60 minutes per procedure
  • +5 more outcomes

Companies that use NuVasive

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

NuVasive technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

NuVasive partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Globus MedicalcoreStrategic or Co-development Partner · 1 February 2023Globus Medical completed acquisition of NuVasive for $3.1 billion in February 2023, creating one of the largest entities in the spine and musculoskeletal space. The merger combined Globus Medical's Excelsius robotic platform with NuVasive's X360 lateral surgery portfolio and Advanced Materials Science technologies.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

NuVasive competitors and assessment

Company assessment

Direct peers

  • Medtronic: Medtronic is NuVasive's largest direct competitor across spine implants, robotic navigation (Mazor), and intraoperative neuromonitoring (NVM5 competes with Medtronic's nerve monitoring portfolio that holds 18% global share versus NuVasive's 15%).
  • Alphatec Holdings: Alphatec is a pure-play spine company offering lateral, posterior fixation, and biologics portfolios that directly overlap with NuVasive's X360, Reline, and regenerative biologics lines, with significant share of voice in the surgeon training and lateral approach segments.
  • Orthofix Medical: Orthofix (which merged with SeaSpine) competes with NuVasive across spine implants, fixation, motion preservation, and orthobiologics, and overlaps in the pediatric/EOS segment where NuVasive's MAGEC rod competes with Orthofix's pediatric portfolio.

Broad incumbents

  • Stryker: Stryker is a diversified medtech incumbent with a meaningful spine and neurosurgery franchise (including acquired Wright Medical assets) plus the Mako orthopedic robotics platform, positioning it as a broad competitor in robotic-enabled surgery that overlaps with ExcelsiusGPS.
  • Johnson & Johnson (DePuy Synthes): Johnson & Johnson's DePuy Synthes spine division competes with NuVasive across interbody devices, fixation, and emerging enabling technologies; the broader J&J medtech R&D and capital resources make it a deep-pocketed incumbent competitor.
  • Zimmer Biomet: Zimmer Biomet competes in spine via its spine and CMFT portfolio and offers the ROSA robotic platform for spine and brain surgery, overlapping with ExcelsiusGPS navigation and NuVasive's broader Enabling Tech push into orthopedics through ExcelsiusFlex.
  • Boston Scientific: Boston Scientific overlaps with NuVasive through its neuromodulation and pain franchise (including spinal cord stimulation platforms) that competes with NuVasive's neuromonitoring and adjacent chronic pain opportunities, particularly after Nevro joined Globus Medical.

Emerging players

  • Brainlab: Brainlab is a navigation and surgical software specialist whose spine imaging and computer-assisted surgery platform competes with NuVasive's ExcelsiusHub and Excelsius3D in the navigation-only segment of the enabling-tech stack.

Others

  • Nevro Corp: Nevro (acquired by Globus Medical in 2025) provides the HFX spinal cord stimulation platform for chronic pain; not a NuVasive competitor per se but a now-sibling asset within the combined Globus-NuVasive platform expanding into neuromodulation.
  • Carl Zeiss Meditec (ZEISS Medical Technology): ZEISS Medical Technology supplies intraoperative imaging and visualization hardware that integrates with multiple surgical robotics platforms (including competitive offerings with Globus/NuVasive Excelsius workflows) and serves as a complementary or substitute imaging source in spine ORs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

NuVasive social profiles

Digital presence

NuVasive compliance and trust

Trust signal

Compliance2 records

NuVasive financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NuVasive leadership team

Management profile

Number of profiles

Profiles9 records

NuVasive subsidiaries and ownership

Company hierarchy

Subsidiaries14 records

NuVasive funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NuVasive M&A and investment

M&A and investment

M&A5 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NuVasive

What does NuVasive do?

NuVasive designs, manufactures, and sells medical devices for spine surgery, including spinal implants (interbody spacers, fixation systems), minimally invasive surgical platforms (X360 lateral single-position surgery, XLIF), advanced biomaterials (Modulus, HEDRON, Cohere porous titanium/PEEK implants), robotic navigation systems (ExcelsiusGPS, ExcelsiusHub), intraoperative neuromonitoring (NVM5, NCS clinical services), and regenerative biologics. Products are sold directly to hospitals, ambulatory surgery centers, and spine surgeons globally across 40+ countries.

Is NuVasive a public or private company?

NuVasive is a private company. It is classified as corporate owned and is currently acquired.

When was NuVasive founded?

NuVasive was founded in 2001. It employs 1,001 to 5,000 people.

Where is NuVasive based?

NuVasive is headquartered in San Diego, United States, in the North America region.

How does NuVasive make money?

Four revenue lines are on record. Spinal implants and surgical instruments are the primary driver. The others are enabling technologies, biologics and regenerative products and intraoperative neuromonitoring services (NCS).

Who are NuVasive's main competitors?

Direct peers on record are Medtronic, Alphatec Holdings and Orthofix Medical. Broad incumbents are Stryker, Johnson & Johnson (DePuy Synthes), Zimmer Biomet and Boston Scientific. Brainlab is listed as an emerging player. Others are Nevro Corp and Carl Zeiss Meditec (ZEISS Medical Technology).

Does NuVasive have an API?

No public API is recorded for NuVasive.

What industry is NuVasive in?

NuVasive's product category is Spinal Surgery Medical Devices. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Law360Judge Preserves, But Narrows, IP Verdict Against NuVasiveA Delaware federal judge on Monday upheld much of a jury's infringement findings against NuVasive in a doctor's case over a group of spinal implant patents, while finding the jury's other infringement conclusions lacked sufficient evidence. The ruling narrows the IP verdict while preserving the core infringement determinations.Simply Wall StGlobus Medical (GMED) Stock Looks Like A Bargain At This PriceSimply Wall St's analysis identifies Globus Medical as undervalued, with the stock trading at an 18.5x P/E ratio compared to an industry average of 26.2x and a tailored fair-value estimate of 26.4x, suggesting a significant discount to comparable businesses. BMO Capital maintains an Outperform rating with a US$94 price target, citing confidence in NuVasive acquisition synergies and demand for the robotic-supported implant portfolio as growth drivers. The article notes that closing the valuation gap depends on whether the company can translate these catalysts into resilient margins, with integration and profitability execution remaining key risks.FortunebusinessinsightsNerve Monitoring System Market Size, Share and Growth 2034The global nerve monitoring system market was valued at USD 1.58 billion in 2025 and is projected to reach USD 2.83 billion by 2034, growing at a CAGR of 6.70%, driven by increasing demand for precision in surgical procedures and improved patient safety outcomes. North America holds approximately 40% of the market share, followed by Europe at 25% and Asia-Pacific at 20%, with the United States, Germany, Japan, and China as key regional contributors. Medtronic leads the market with an 18% share, followed by NuVasive at 15%, among other major players including NIHON KOHDEN, Natus, and inomed Medizintechnik.TradingViewGMED Growth Drivers After NuVasive and What Q1 SignalsGlobus Medical reported Q1 2026 adjusted earnings of $1.12 per share, up 64.7% year over year and ahead of consensus estimates, with revenue of $759.9 million also beating expectations as post-merger integration with NuVasive drove operating leverage. Operating margin expanded 358 basis points to 19.8% and gross margin grew 280 basis points to 66.4%, while the company raised full-year adjusted diluted earnings guidance to $4.70-$4.80 and reaffirmed revenue guidance of $3.18-$3.22 billion. Category wins across U.S. Spine (third consecutive quarter of 10% growth), Trauma (up 30.4%), and Enabling Technologies (up 21.1%) signal broad share capture, with management targeting long-term adjusted gross margin in the mid-70s.openPR.comTop Players and Market Competition in the Genu Recurvatum IndustryThe genu recurvatum market, covering knee joint deformity treatments, is projected to grow to $11.49 billion by 2030 at a 7.5% CAGR, driven by advances in orthopedic devices, customized bracing, physiotherapy services, and an aging population. The market features prominent medical device companies including Johnson & Johnson MedTech, Stryker Corporation, DePuy Synthes, and others, with a notable merger occurring in April 2023 when NuVasive, Inc. merged with Globus Medical Inc. to combine their musculoskeletal technology portfolios and expand global reach. The report also highlights product innovations such as LogicMark's February 2025 launch of the Guardian Alert 911 Plus emergency response system with fall detection and 4G LTE connectivity.Financial ExpressTamil Nadu techie built a $12bn empire in the US ‘fixing’ spines – Meet the ‘quietest billionaire’David C. Paul, an Indian engineer from Tamil Nadu who immigrated to the US in the early 1990s, founded Globus Medical in 2003 to develop spinal implants and surgical tools, growing it into a company now valued at approximately $11–12 billion. The company went public on the NYSE in 2012 and developed the ExcelsiusGPS robotic navigation system for spinal surgery, and in 2023 completed a major all-stock merger with NuVasive valued at around $3 billion, creating one of the largest entities in the spine and musculoskeletal space. Paul, who stepped down as CEO in 2017 but remains Executive Chairman, maintains an estimated 15–25% ownership stake and a net worth of approximately $2.3 billion.Financial ExpressTechie from Tamil Nadu built a $12bn empire in the US ‘fixing’ spines- Meet 2026’s quietest billionaireDavid C. Paul, an Indian-born engineer from Tamil Nadu, founded Globus Medical in 2003 in Pennsylvania, building it into a medical device company now valued at $11–12 billion, specializing in spinal implants, instruments, and biologics including the ExcelsiusGPS robotic navigation system. The company went public on the NYSE in 2012 and in 2023 completed an all-stock merger with NuVasive valued at around $3 billion, making Globus shareholders the majority owners and creating one of the largest entities in the spine and musculoskeletal space. Paul, whose estimated net worth stands at $2.3 billion, stepped down as CEO in 2017 but remains Executive Chairman of the Board.openPR.comSegment Evaluation and Major Growth Areas in the Adult Spinal Deformity MarketThe global adult spinal deformity market is projected to reach $3.37 billion by 2030, growing at a CAGR of 5.4%, driven by advances in minimally invasive procedures, image-guided and robotic-assisted surgeries, and expanding healthcare infrastructure. A notable development in the sector occurred in September 2023 when Globus Medical Inc. merged with NuVasive Inc. to combine spinal surgery technology expertise and accelerate innovation in minimally invasive procedures. The market report also highlights emerging trends including advanced diagnostic tools, with Sysmex Astrego AB launching a point-of-care testing system in June 2023.openPR.comSegmentation, Major Trends, and Competitive Overview of the Acute Spinal Cord Injury MarketThe acute spinal cord injury market is projected to reach $9.4 billion by 2030, growing at a compound annual growth rate of 6.1%, driven by advances in neuroregenerative therapies, increased rehabilitation centers, and AI-enabled diagnostics. In February 2023, Globus Medical Inc. acquired NuVasive Inc. for $3.1 billion to expand its musculoskeletal product portfolio and strengthen its position in spinal surgery technology. StatLab, a US-based histology equipment supplier, launched its Diapath instrument suite in the United States in September 2025 to enhance pathology lab operations.openPR.comU.S. Scoliosis Market Set to Boom Rapidly by 2033 | Medtronic • NuVasive • Zimmer BiometCoherent Market Insights released a market research report forecasting the U.S. scoliosis market to expand rapidly through 2033, analyzing industry trends, competitive landscapes, and growth opportunities. The report identifies key industry players including Medtronic, NuVasive, and Zimmer Biomet as major participants in this sector.